We are live on ! Find out more
STAA icon

STAAR Surgical

196 hedge funds and large institutions have $1.36B invested in STAAR Surgical in 2025 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 45 increasing their positions, 64 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 65 | Existing positions closed: 39

50% more capital invested

Capital invested by funds: $904M → $1.36B (+$455M)

15% more funds holding

Funds holding: 170196 (+26)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

6.23% less ownership

Funds ownership: 108.74%102.52% (-6.2%)

30% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 64

43% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $17.7M

Holders
196
Holders Change
+26
Holders Change %
+15.29%
% of All Funds
2.57%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
65
Increased
45
Reduced
64
Closed
39
Calls
$10.2M
Puts
$17.7M
Net Calls
-$7.57M
Net Calls Change
-$8.85M
Name Holding Trade Value Shares
Change
Change in
Stake
BC
1
Broadwood Capital
New York
$363M
BlackRock
2
BlackRock
New York
$195M -$2.68M -112,193 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$115M -$2.9M -121,644 -3%
YC
4
Yunqi Capital
Hong Kong
$67.2M +$2.12M +88,773 +4%
State Street
5
State Street
Massachusetts
$51.3M -$2.19M -91,941 -5%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$48.7M +$43.2M +1,813,508 New
MF
7
Magnetar Financial
Illinois
$32.4M +$28.7M +1,204,371 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$31.5M -$453K -18,998 -2%
Goldman Sachs
9
Goldman Sachs
New York
$26.2M +$18.9M +794,020 +436%
AAM
10
Alpine Associates Management
Florida
$24.5M +$21.8M +913,087 New
SGCM
11
Sand Grove Capital Management
United Kingdom
$22.3M +$19.8M +829,123 New
ACM
12
American Capital Management
New York
$20M -$989K -41,490 -5%
WIC
13
Water Island Capital
New York
$17.7M +$15.7M +658,317 New
SC
14
Slotnik Capital
Texas
$17.1M +$15.1M +635,000 New
AA
15
AQR Arbitrage
Connecticut
$16.9M +$15M +630,500 New
KC
16
Kryger Capital
United Kingdom
$16.8M +$14.9M +623,937 New
Dimensional Fund Advisors
17
Dimensional Fund Advisors
Texas
$15.9M -$4.64M -194,414 -25%
Northern Trust
18
Northern Trust
Illinois
$14M +$163K +6,816 +1%
SCM
19
Soleus Capital Management
Connecticut
$13.4M -$59.2M -2,484,733 -83%
Morgan Stanley
20
Morgan Stanley
New York
$13.3M -$19.4M -815,712 -62%
Charles Schwab
21
Charles Schwab
California
$12.9M +$138K +5,808 +1%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$10.1M +$8.02M +336,285 +835%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$7.99M -$223K -9,372 -3%
GCL
24
Glazer Capital LLC
New York
$7.71M +$6.84M +287,000 New
Principal Financial Group
25
Principal Financial Group
Iowa
$6.89M -$834K -34,993 -12%

STAA Hedge Fund Activity: Q3 2025 in Review

196 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q3 2025, worth a combined $1.36B — up 50% from $904M a quarter earlier.

Buyers outnumbered sellers: 65 funds opened new STAA positions and 39 closed out — a net gain of 26 holders — while 45 added to existing stakes and 64 trimmed.

The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $43.2M. The largest seller was Soleus Capital Management, cutting an estimated $59.2M.

  • 196 institutional investors held STAAR Surgical (STAA) as of Q3 2025, up from 170 in Q2 2025.
  • Funds reported $1.36B of STAAR Surgical stock for Q3 2025, up 50% quarter-over-quarter.
  • 65 funds opened new STAAR Surgical positions in Q3 2025 and 39 closed out, a net change of +26 holders.
  • The largest STAAR Surgical buyer in Q3 2025 was Balyasny Asset Management, an estimated $43.2M added.
  • The largest STAAR Surgical seller in Q3 2025 was Soleus Capital Management, an estimated $59.2M sold.

Based on aggregated 13F filings for Q3 2025.